Pharmacovigilance
Pharmacovigilance
| Product | Date | Safety information | Attachments |
|---|---|---|---|
| Protelos® - Strontium ranelate | 2013-05-27 | Increased risk of myocardial infarction |
|
| Miacalcic® - Calcitonin | 2013-05-11 | increased risk of malignancies with long term calcitonin use |
|
| Solpadeine® - Paracetamol, Caffeine, Codeine Phosphate | 2013-05-07 | The use of codeine containing products for children after tonsillectomy and /or adenoidectomy surgery |
|
| Vastarel® - Trimetazidine | 2013-05-01 | Outcome of the Benefit-Risk Re-evaluation of Trimetazidine |
|
| AVASTIN® - Bevacizumab | 2013-04-07 | Cases of Necrotizing Fasciitis Reported with AVASTIN |
|
| MabThera® - Rituximab | 2013-04-01 | Risk of Toxic Epidermal Necrolysis And Stevens-Johnson-Syndrome |
|
| SPRYCEL® - Dasatinib | 2013-01-27 | Risk of (PAH) Pulmonary Arterial Hypertension |
|
| Valdoxan® - Agomelatine | 2013-01-21 | Risk of hepatotoxicity with agomelatine |
|
| Arava® - leflunomide | 2012-12-23 | Risk of hepatotoxicity Risk of serious birth defects |
|
| Wellbutrin®/Zyban® - bupropion | 2012-12-15 | Increased risk of congenital cardiovascular malformations |